A Dominant-Negative PPARgamma Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle Cells

Joey Z Liu1, Christopher J Lyon, Willa A Hsueh

  • 1The Methodist Hospital Research Institute, Houston, TX 77030, USA.

PPAR Research
|March 20, 2010
PubMed

Insights

A dominant-negative PPARgamma mutant acts as a growth factor in human coronary artery smooth muscle cells, promoting cell cycle progression and proliferation. This suggests PPARgamma plays a key role in regulating vascular smooth muscle cell growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cardiovascular Research

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands typically inhibit cell proliferation.
  • The role of PPARgamma in vascular smooth muscle cell (VSMC) growth regulation requires further elucidation.

Purpose of the Study:

  • To investigate the effect of a dominant-negative PPARgamma mutant on human coronary artery smooth muscle cell (CASMC) proliferation.
  • To elucidate the underlying molecular mechanisms, including cell cycle regulation and signaling pathways.

Main Methods:

  • Adenovirus-mediated expression of dominant-negative (DN) PPARgamma and wild-type (WT)/constitutively-active (CA) PPARgamma in CASMCs.
  • Assessment of cell cycle progression (BrdU incorporation, G1 to S phase transition).
  • Analysis of cell cycle regulatory proteins (Rb, CDC2, cyclins, MCM7) and ERK MAPKs phosphorylation.

Main Results:

  • DN-PPARgamma expression promoted G1 to S phase cell cycle progression and proliferation in CASMCs.
  • DN-PPARgamma enhanced phosphorylation of Rb, CDC2, and ERK MAPKs, and increased cyclin A, B1, D1, and MCM7 expression.
  • Overexpression of WT or CA PPARgamma inhibited cell cycle progression, while DN-PPARgamma effects were dependent on endogenous PPARgamma function.

Conclusions:

  • A dominant-negative PPARgamma mutant acts as a growth factor in CASMCs, promoting cell cycle progression.
  • DN-PPARgamma modulates cell cycle regulators and MAPK signaling pathways to drive VSMC proliferation.
  • These findings reveal a novel role for PPARgamma in controlling vascular smooth muscle cell growth.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...